Word

RECODE THERAPEUTICS

Status

Pending

Status Code

731

Status Date

Thursday, May 23, 2024

Serial Number

97354266

Mark Type

4

Filing Date

Friday, April 8, 2022

Published for Opposition

Tuesday, March 28, 2023

Trademark Owner History

ReCode Therapeutics, Inc. - Owner At Publication

Classifications

41 Providing online non-downloadable articles, books, magazines, journals, and scientific texts in the fields of genetic medicine and drug delivery

9 Downloadable electronic publications in the nature of articles, books, magazines, journals, and scientific texts in the fields of genetic medicine and drug delivery

5 Medicines for the modification of genes and treatment of diseases, for use in the treatment of respiratory diseases, lung diseases, central nervous system diseases, immunodeficiency and autoimmune diseases, infectious diseases, liver diseases, metabolic disorders, muscular diseases, and cancer; cell and gene therapy biological preparations and pharmaceutical preparations with protein expression, all for the treatment of respiratory diseases, lung diseases, central nervous system diseases, immunodeficiency and autoimmune diseases, infectious diseases, liver diseases, metabolic disorders, muscular diseases, and cancer; drug carriers for medical use, namely, delivery agents in the form of non-viral lipid nanoparticles for delivering drugs to human organs that facilitate the delivery of a wide range of pharmaceuticals; pharmaceutical preparations for the treatment and prevention of respiratory diseases, lung diseases, central nervous system diseases, immunodeficiency and autoimmune diseases, infectious diseases, liver diseases, metabolic disorders, muscular diseases, and cancer

44 Providing medical information in the fields of genetic medicine and drug delivery

42 Scientific and biotechnology research and analysis in the fields of cell and gene therapy and drug delivery; research and development of medicines and drug delivery platforms for the treatment of diseases; providing scientific research and medical research information in the fields of genetic medicine and drug delivery; medical and scientific research in the field of pharmaceuticals; pharmaceutical research and products development of pharmaceuticals for the treatment of respiratory diseases, lung diseases, central nervous system diseases, immunodeficiency and autoimmune diseases, infectious diseases, liver diseases, metabolic disorders, muscular diseases, and cancer

"THERAPEUTICS"

Trademark Events

Feb 1, 2023

Examiner's Amendment/Priority Action E-Mailed

Apr 12, 2022

New Application Entered

Apr 13, 2022

New Application Office Supplied Data Entered

Jan 25, 2023

Assigned To Examiner

Feb 1, 2023

Examiners Amendment And/Or Priority Action - Completed

Feb 1, 2023

Notification Of Examiner's Amendment/Priority Action E-Mailed

Feb 1, 2023

Assigned To Lie

Feb 1, 2023

Combined Examiner's Amendment/Priority Action Entered

Feb 18, 2023

Approved For Pub - Principal Register

Feb 3, 2023

Teas Response To Office Action Received

Feb 4, 2023

Correspondence Received In Law Office

Feb 4, 2023

Teas/Email Correspondence Entered

Mar 28, 2023

Official Gazette Publication Confirmation E-Mailed

Mar 8, 2023

Notification Of Notice Of Publication E-Mailed

Mar 28, 2023

Published For Opposition

May 23, 2023

Noa E-Mailed - Sou Required From Applicant

Nov 14, 2023

Sou Teas Extension Received

Nov 14, 2023

Sou Extension 1 Filed

Nov 14, 2023

Sou Extension 1 Granted

Nov 16, 2023

Notice Of Approval Of Extension Request E-Mailed

May 23, 2024

Sou Teas Extension Received

May 23, 2024

Sou Extension 2 Filed

May 23, 2024

Sou Extension 2 Granted

May 24, 2024

Notice Of Approval Of Extension Request E-Mailed